F

Fennec Pharmaceuticals
D

FENC

7.62000
USD
0.13
(1.74%)
مغلق
حجم التداول
2,083
الربح لكل سهم
-0
العائد الربحي
-
P/E
-29
حجم السوق
260,249,640
أصول ذات صلة الأخبار المقالات

العنوان: Fennec Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.